Patents by Inventor Patrick Dennistoun McGorry

Patrick Dennistoun McGorry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PREVENTION OF PSYCHOTIC DISORDERS AND/OR TREATMENT OF PSYCHOTIC SYMPTOMS
    Publication number: 20210251936
    Abstract: The present invention relates to methods of preventing a psychotic disorder in a subject in need of intervention including administering to the subject a composition including EPA (eicosapentanoic acid) and DHA (docosahexaenoic acid). Methods of treating pre-psychotic symptoms in a subject, including administering to the subject a composition including EPA and DHA are also included.
    Type: Application
    Filed: May 3, 2021
    Publication date: August 19, 2021
    Applicant: Orygen Youth Health Research Centre
    Inventors: Gunter Paul Amminger, Patrick Dennistoun McGorry
  • Prevention of psychotic disorders and/or treatment of psychotic symptoms
    Patent number: 11013708
    Abstract: The present invention relates to methods of preventing a psychotic disorder in a subject in need of intervention including administering to the subject a composition including EPA (eicosapentanoic acid) and DHA (docosahexaenoic acid). Methods of treating pre-psychotic symptoms in a subject, including administering to the subject a composition including EPA and DHA are also included.
    Type: Grant
    Filed: May 9, 2019
    Date of Patent: May 25, 2021
    Assignee: Orygen Youth Health Research Centre
    Inventors: Gunter Paul Amminger, Patrick Dennistoun McGorry
  • PREVENTION OF PSYCHOTIC DISORDERS AND/OR TREATMENT OF PSYCHOTIC SYMPTOMS
    Publication number: 20190321320
    Abstract: The present invention relates to methods of preventing a psychotic disorder in a subject in need of intervention including administering to the subject a composition including EPA (eicosapentanoic acid) and DHA (docosahexaenoic acid). Methods of treating pre-psychotic symptoms in a subject, including administering to the subject a composition including EPA and DHA are also included.
    Type: Application
    Filed: May 9, 2019
    Publication date: October 24, 2019
    Applicant: Orygen Youth Health Research Centre
    Inventors: Gunter Paul Amminger, Patrick Dennistoun McGorry
  • Prevention of psychotic disorders and/or treatment of psychotic symptoms
    Patent number: 10314805
    Abstract: The present invention relates to methods of preventing a psychotic disorder in a subject in need of intervention including administering to the subject a composition including EPA (eicosapentanoic acid) and DHA (docosahexaenoic acid). Methods of treating pre-psychotic symptoms in a subject, including administering to the subject a composition including EPA and DHA are also included.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: June 11, 2019
    Assignee: Orygen Youth Health Research Centre
    Inventors: Gunter Paul Amminger, Patrick Dennistoun McGorry
  • PREVENTION OF PSYCHOTIC DISORDERS AND/OR TREATMENT OF PSYCHOTIC SYMPTOMS
    Publication number: 20180104209
    Abstract: The present invention relates to methods of preventing a psychotic disorder in a subject in need of intervention including administering to the subject a composition including EPA (eicosapentanoic acid) and DHA (docosahexaenoic acid). Methods of treating pre-psychotic symptoms in a subject, including administering to the subject a composition including EPA and DHA are also included.
    Type: Application
    Filed: December 15, 2017
    Publication date: April 19, 2018
    Applicant: Orygen Youth Health Research Centre
    Inventors: Gunter Paul Amminger, Patrick Dennistoun McGorry
  • Prevention of psychotic disorders and/or treatment of psychotic symptoms
    Patent number: 9884034
    Abstract: The present invention relates to methods of preventing a psychotic disorder in a subject in need of intervention including administering to the subject a composition including EPA (eicosapentanoic acid) and DHA (docosahexaenoic acid). Methods of treating pre-psychotic symptoms in a subject, including administering to the subject a composition including EPA and DHA are also included.
    Type: Grant
    Filed: May 5, 2014
    Date of Patent: February 6, 2018
    Assignee: Orygen Youth Health Research Centre
    Inventors: Gunter Paul Amminger, Patrick Dennistoun McGorry
  • PREVENTION OF PSYCHOTIC DISORDERS AND/OR TREATMENT OF PSYCHOTIC SYMPTOMS
    Publication number: 20140323571
    Abstract: The present invention relates to methods of preventing a psychotic disorder in a subject in need of intervention including administering to the subject a composition including EPA (eicosapentanoic acid) and DHA (docosahexaenoic acid). Methods of treating pre-psychotic symptoms in a subject, including administering to the subject a composition including EPA and DHA are also included.
    Type: Application
    Filed: May 5, 2014
    Publication date: October 30, 2014
    Applicant: Orygen Youth Health Research Centre
    Inventors: Gunter Paul Amminger, Patrick Dennistoun McGorry
  • PREVENTION OF PSYCHOTIC DISORDERS AND/OR TREATMENT OF PSYCHOTIC SYMPTOMS
    Publication number: 20110166229
    Abstract: The present invention relates to methods of preventing a psychotic disorder in a subject in need of intervention including administering to the subject a composition including EPA (eicosapentanoic acid) and DHA (docosahexaenoic acid). Methods of treating pre-psychotic symptoms in a subject, including administering to the subject a composition including EPA and DHA are also included.
    Type: Application
    Filed: September 9, 2008
    Publication date: July 7, 2011
    Applicant: ORYGEN RESEARCH CENTRE
    Inventors: Gunter Paul Amminger, Patrick Dennistoun McGorry